Clinical Trial: Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy Controls

U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07857837) titled 'Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy Controls' on Sept. 29.

Brief Summary: The purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of sulthiame in participants with mild and moderate renal impairment compared to those in healthy participants with normal renal function.

Study Start Date: Sept. 29

Study Type: INTERVENTIONAL

Condition: Renal Impairment

Intervention: DRUG: Sulthiame

Tablet for oral administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shionogi

Disclaimer: Curated by HT Syndication....